242 related articles for article (PubMed ID: 36276947)
21. Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.
Xu T; Chai J; Wang K; Jia Q; Liu Y; Wang Y; Xu J; Yu K; Zhao D; Ma J; Fan L; Yan Q; Guo S; Chen G; Chen Q; Xiao H; Liu F; Qi C; Liang R; Li M; Wang Z
Front Oncol; 2021; 11():638154. PubMed ID: 34221962
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma.
Jin Y; Wang Z; He D; Zhu Y; Chen X; Cao K
Cancer Med; 2021 Dec; 10(23):8693-8707. PubMed ID: 34668665
[TBL] [Abstract][Full Text] [Related]
23.
Sun J; Zhu X; Zhao Y; Zhou Q; Qi R; Liu H
Pharmgenomics Pers Med; 2021; 14():397-408. PubMed ID: 33833551
[TBL] [Abstract][Full Text] [Related]
24. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma.
Qi X; Qi C; Qin B; Kang X; Hu Y; Han W
Front Oncol; 2020; 10():541330. PubMed ID: 33072571
[No Abstract] [Full Text] [Related]
25. Roles of RNA m
Cui W; Luo C; Zhou L; Yu T; Meng Y; Yu Q; Lei Z; Wang Y; Peng L; Luo Q; Tang D; Sun R; Yu L
Am J Cancer Res; 2024; 14(4):1768-1783. PubMed ID: 38726285
[TBL] [Abstract][Full Text] [Related]
26. Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL).
Feng P; Li H; Pei J; Huang Y; Li G
Front Genet; 2021; 12():625414. PubMed ID: 33643388
[TBL] [Abstract][Full Text] [Related]
27. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.
Zhang Q; Zhu Z; Guan J; Zheng C
Front Oncol; 2022; 12():904614. PubMed ID: 35814424
[TBL] [Abstract][Full Text] [Related]
28. Pan-Cancer Molecular Characterization of m
Zhu J; Xiao J; Wang M; Hu D
Front Oncol; 2020; 10():618374. PubMed ID: 33585244
[TBL] [Abstract][Full Text] [Related]
29. The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment.
Wang W; Xu SW; Teng Y; Zhu M; Guo QY; Wang YW; Mao XL; Li SW; Luo WD
Front Cell Dev Biol; 2021; 9():779123. PubMed ID: 34805183
[No Abstract] [Full Text] [Related]
30. Expression of N
Xie Z; Li M; Hong H; Xu Q; He Z; Peng Z
Bioengineered; 2021 Dec; 12(1):6115-6133. PubMed ID: 34482808
[TBL] [Abstract][Full Text] [Related]
31. Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma.
Wang L; Yuan W; Li L; Shen Z; Geng Q; Zheng Y; Zhao J
J Immunol Res; 2022; 2022():9544827. PubMed ID: 35983077
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
33. The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
Keane C; Tobin J; Gunawardana J; Francis S; Gifford G; Gabrielli S; Gill A; Stevenson W; Talaulikar D; Gould C; Jain S; Birch S; Hertzberg M; Gandhi MK
Eur J Haematol; 2019 Sep; 103(3):200-207. PubMed ID: 31211907
[TBL] [Abstract][Full Text] [Related]
34. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
35. Immunogenic Cell Death-related Signature Evaluates the Tumor Microenvironment and Predicts the Prognosis in Diffuse Large B-Cell Lymphoma.
Huang S; Liu W; Zhao Q; Chen T; Huang R; Dong L; Nian Z; Yang L
Biochem Genet; 2024 Mar; ():. PubMed ID: 38446321
[TBL] [Abstract][Full Text] [Related]
36. Identification of
Xiang X; Gao LM; Zhang Y; Tang Y; Zhao S; Liu W; Ye Y; Zhang W
Front Genet; 2022; 13():849422. PubMed ID: 35711924
[TBL] [Abstract][Full Text] [Related]
37. Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma.
Jiang Y; Sun H; Xu H; Hu X; Wu W; Lv Y; Wang J; Liu S; Zhai Y; Tian L; Wang Y; Zhao Z
Front Genet; 2022; 13():872001. PubMed ID: 35754837
[TBL] [Abstract][Full Text] [Related]
38. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
39. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics.
Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L
Front Oncol; 2022; 12():941724. PubMed ID: 36212395
[TBL] [Abstract][Full Text] [Related]
40. Identification and Validation of a Prognostic Gene Signature for Diffuse Large B-Cell Lymphoma Based on Tumor Microenvironment-Related Genes.
Pan T; He Y; Chen H; Pei J; Li Y; Zeng R; Xia J; Zuo Y; Qin L; Chen S; Xiao L; Zhou H
Front Oncol; 2021; 11():614211. PubMed ID: 33692952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
